COMMUNIQUÉS West-GlobeNewswire

Hemispherx Biopharma Announces Significant Progress in its Ampligen Pancreatic Cancer Program and Multiple Ampligen+Checkpoint Blockade Immuno-Oncology Programs
13/03/2019
Hemispherx Provides Quarterly Summary of Rapidly Advancing Oncology Clinical Programs OCALA, Fla., March 13, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an [...]
Indiva Diversifying to Excel in Red Hot Extracts Market -- CFN Media
13/03/2019
SEATTLE, March 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Conatus Late-breaker Oral Presentation at EASL Meeting to Detail Results of ENCORE-PH Phase 2b Clinical Trial in Patients with NASH Cirrhosis and Severe Portal Hypertension
13/03/2019
SAN DIEGO, March 13, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today the acceptance of an abstract for a late-breaker oral presentation at The International Liver Congress™ 2019, the [...]
Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Acer Therapeutics to Participate in Upcoming Investor Conferences
13/03/2019
NEWTON, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life- [...]
Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th
13/03/2019
LAVAL, Quebec, March 13, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Vaccinex, Inc. to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 19, 2019
13/03/2019
ROCHESTER, N.Y., March 13, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today [...]
The 3D designed Conformis Hip System Announced at the 2019 AAOS conference
13/03/2019
Designed to enhance operational efficiency for the surgeon and improve patient outcomes, the Conformis Hip System is the most advanced, patient conforming hip replacement system available BILLERICA, Mass., March 13, [...]
Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101
13/03/2019
U.S. and European patent protections through at least August 2034 NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology [...]
Mustang Bio to Present at Oppenheimer’s 29th Annual Healthcare Conference
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell ( [...]
Daxor Corporation to Showcase Reduction in Mortality and Hospital Readmissions with BVA-100® Guided-Care at the Annual Meeting of the American College of Cardiology Expo 2019
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today [...]
Positive FDA Meeting Outlines Path Ahead for Akari Therapeutics’s Coversin in Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
13/03/2019
HSCT-TMA trial in pediatric patients expected to start Q4 2019 following recent FDA feedback NEW YORK and LONDON, March 13, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company [...]
Oncology Venture rearranges its financing agreement with EHGOS (Alpha Blue Ocean)
13/03/2019
Press release Hoersholm, Denmark, March 13, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today announces a modification of the conditions of the financing agreement entered into with European High [...]
Veradigm™ Strengthens its Health Plan and Analytics Solutions by Finalizing Partnership with Pulse8
13/03/2019
CHICAGO, March 13, 2019 (GLOBE NEWSWIRE) -- Veradigm™, an Allscripts (NASDAQ: MDRX), business unit, announced today that it has strengthened its strategic relationship with Pulse8, a leader in healthcare analytics and [...]
Cedars Sinai Uses AlloSure in Tocilizumab Trial
13/03/2019
Cedars Sinai enrolls first patient in a study that uses AlloSure to characterize patient response to therapy BRISBANE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics [...]
ALGENEX appoints new Strategic Advisory Board (SAB)
13/03/2019
PRESS RELEASE ALGENEX appoints new Strategic Advisory Board (SAB) Advisors include recognized industry leaders in international healthcare Madrid (Spain), March 13, 2019 – ALGENEX SL (the “company”), a private [...]
AIT Therapeutics to Participate at Two Investor Conferences in March
13/03/2019
GARDEN CITY, N.Y., and REHOVOT, Israel, March 13, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
13/03/2019
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular [...]
Tauriga Sciences Inc. Further Increases its Production of Tauri-Gum Inventory to Support its Ongoing Commercial Launch
13/03/2019
New York, NY, March 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]

Pages